Joshua Pierce NC State University
The failure of frontline antibiotics in the clinic is one of the most serious threats to human health and requires a multitude of novel therapeutics and innovative treatment approaches to curtail the growing crisis. In addition to traditional resistance mechanisms resulting in the lack of efficacy of many antibiotics, most chronic and recurring infections are further made tolerant to antibiotic action by the presence of biofilms. Herein, we report an expanded set of 5-benzylidene-4-oxazolidinones that are able to inhibit the formation of Staphylococcus aureus biofilms, disperse preformed biofilms and in combination with common antibiotics are able to significantly reduce the bacterial load in a robust collagen-matrix model of biofilm infection.
download asset Synoxa_19_Final.pdf 7 MB [opens in a new tab] cloud_download
pdf : 7 MB
download asset Electronic Supplementary Information FINAL.pdf 2 MB [opens in a new tab] cloud_download
pdf : 2 MB
Electronic Supplementary Information FINAL